Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Minerva Endocrinol ; 41(3): 291-7, 2016 Sep.
Article in English | MEDLINE | ID: mdl-25356519

ABSTRACT

BACKGROUND: Childhood obesity increases cardiovascular risk during adulthood. Retinol-binding protein-4, a pro-inflammatory adipokine, associated with obesity and insulin resistance also plays a role in atherogenesis in adults. The goal of this study was to identify the relation between RBP4 and atherogenic markers in obese children. METHODS: In a cross-sectional study, obese and non-obese children (8-18 years) were prospectively recruited from a pediatric Appalachian population. Clinical markers such as lipid profile, HbA1c, markers of insulin resistance and plasma levels of RBP4, sVCAM-1 and oxidized-low-density lipoprotein (Ox-LDL) were measured. RESULTS: Compared to non-obese children, RBP4 (P=0.016) and Ox-LDL (P<0.001) were significantly higher in obese children and were positively correlated with Body Mass Index (P<0.001), BMI-SDS (Standard-Deviation Score) (P<0.001) and waist circumference (P=0.03). CONCLUSIONS: No significant correlation was found between inflammatory markers and Homeostatic Model Assessment-2, HDL, triglycerides, and HbA1c in obese children.


Subject(s)
Atherosclerosis/blood , Pediatric Obesity/blood , Retinol-Binding Proteins, Plasma/analysis , Adolescent , Atherosclerosis/complications , Biomarkers/blood , Body Mass Index , Child , Cross-Sectional Studies , Female , Humans , Lipoproteins, LDL/blood , Male , Pediatric Obesity/complications , Puberty
2.
South Med J ; 100(4): 409-10, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17458405

ABSTRACT

Ezetimibe is a lipid-lowering agent that inhibits the intestinal absorption of cholesterol and other related phytosterols. It is used alone or in combination with other lipid-lowering agents in the treatment of various forms of hypercholesterolemia. Since its FDA approval in 2002, there are no known citations of ezetimibe-induced pancreatitis.


Subject(s)
Anticholesteremic Agents/adverse effects , Azetidines/adverse effects , Pancreatitis, Acute Necrotizing/chemically induced , Anticholesteremic Agents/therapeutic use , Azetidines/therapeutic use , Diagnosis, Differential , Dyslipidemias/drug therapy , Ezetimibe , Female , Follow-Up Studies , Humans , Lipase/blood , Middle Aged , Pancreatitis, Acute Necrotizing/diagnosis , Pancreatitis, Acute Necrotizing/enzymology
4.
Clin Rheumatol ; 26(6): 996-8, 2007 Jun.
Article in English | MEDLINE | ID: mdl-16555017

ABSTRACT

We report a case of Crohn's disease that was associated with marked dermatologic manifestations depicting necrotizing vasculitis around the ankles. On further evaluation, this patient was found to have aortic narrowing, which fit the criteria for Takayasu's arteritis.


Subject(s)
Crohn Disease/complications , Takayasu Arteritis/complications , Takayasu Arteritis/pathology , Vasculitis/etiology , Adult , Ankle/blood supply , Ankle/pathology , Aorta/pathology , Female , Humans , Skin Diseases/etiology , Takayasu Arteritis/diagnosis , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...